Table of Contents Author Guidelines Submit a Manuscript
Journal of Transplantation
Volume 2014, Article ID 913634, 5 pages
http://dx.doi.org/10.1155/2014/913634
Clinical Study

Use of Adjuvant Sorafenib in Liver Transplant Recipients with High-Risk Hepatocellular Carcinoma

1Johns Hopkins Medicine, Division of Gastroenterology and Hepatology, Sibley Memorial Hospital, 5215 Loughboro Road, NW Suite No. 300, Washington, DC 20016, USA
2Georgetown University School of Medicine, Lombardi Cancer Center, 3800 Reservoir Road NW, Washington, DC 20007, USA
3Georgetown University Hospital, Georgetown Transplant Institute, 3800 Reservoir Road NW, Washington, DC 20007, USA

Received 15 January 2014; Accepted 24 February 2014; Published 10 April 2014

Academic Editor: P. Burra

Copyright © 2014 Kirti Shetty et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Kirti Shetty, Chiranjeev Dash, and Jacqueline Laurin, “Use of Adjuvant Sorafenib in Liver Transplant Recipients with High-Risk Hepatocellular Carcinoma,” Journal of Transplantation, vol. 2014, Article ID 913634, 5 pages, 2014. https://doi.org/10.1155/2014/913634.